Fmr LLC raised its stake in shares of Teladoc Inc (NYSE:TDOC) by 35.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,075,000 shares of the company’s stock after buying an additional 796,647 shares during the period. Fmr LLC owned approximately 0.07% of Teladoc worth $50,738,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in TDOC. BlackRock Inc. increased its stake in Teladoc by 2.5% in the third quarter. BlackRock Inc. now owns 61,149 shares of the company’s stock valued at $1,120,000 after buying an additional 1,463 shares in the last quarter. Jaffetilchin Investment Partners LLC increased its stake in shares of Teladoc by 11.0% in the third quarter. Jaffetilchin Investment Partners LLC now owns 46,168 shares of the company’s stock valued at $845,000 after buying an additional 4,557 shares during the period. BlackRock Advisors LLC increased its stake in shares of Teladoc by 1.5% in the third quarter. BlackRock Advisors LLC now owns 452,548 shares of the company’s stock valued at $8,286,000 after buying an additional 6,578 shares during the period. State Street Corp increased its stake in shares of Teladoc by 2.5% in the fourth quarter. State Street Corp now owns 381,703 shares of the company’s stock valued at $6,309,000 after buying an additional 9,146 shares during the period. Finally, DORCHESTER WEALTH MANAGEMENT Co increased its stake in shares of Teladoc by 80.0% in the third quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 27,000 shares of the company’s stock valued at $494,000 after buying an additional 12,000 shares during the period. 46.61% of the stock is currently owned by institutional investors and hedge funds.
Teladoc Inc (NYSE:TDOC) opened at 23.30 on Tuesday. The stock has a 50 day moving average price of $21.13 and a 200-day moving average price of $18.39. The stock’s market cap is $1.26 billion. Teladoc Inc has a 12-month low of $9.08 and a 12-month high of $23.75.
Teladoc (NYSE:TDOC) last issued its earnings results on Wednesday, March 1st. The company reported ($0.31) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.35) by $0.04. Teladoc had a negative return on equity of 32.68% and a negative net margin of 69.15%. The firm had revenue of $37.40 million for the quarter, compared to analysts’ expectations of $36.73 million. During the same quarter last year, the firm earned ($0.39) earnings per share. The firm’s revenue for the quarter was up 65.5% compared to the same quarter last year. On average, equities analysts expect that Teladoc Inc will post ($0.87) earnings per share for the current year.
var userip;Your IP Address: document.write(userip);
Several equities research analysts have weighed in on TDOC shares. Chardan Capital restated a “buy” rating and set a $24.00 price target on shares of Teladoc in a report on Tuesday, January 10th. Craig Hallum started coverage on Teladoc in a report on Monday, November 28th. They set a “buy” rating and a $24.00 price target on the stock. Canaccord Genuity started coverage on Teladoc in a report on Wednesday, January 4th. They set a “buy” rating and a $24.00 price target on the stock. Zacks Investment Research upgraded Teladoc from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a report on Tuesday, January 3rd. Finally, Cantor Fitzgerald cut their price target on Teladoc from $25.00 to $23.00 and set a “buy” rating on the stock in a report on Thursday, January 19th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Teladoc presently has an average rating of “Buy” and an average target price of $24.50.
In related news, major shareholder Trident Capital Fund Vi Lp sold 250,000 shares of Teladoc stock in a transaction on Tuesday, January 24th. The stock was sold at an average price of $15.79, for a total value of $3,947,500.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Mark Hirschhorn sold 10,000 shares of Teladoc stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $17.84, for a total value of $178,400.00. Following the completion of the transaction, the vice president now owns 240,887 shares in the company, valued at approximately $4,297,424.08. The disclosure for this sale can be found here. Insiders sold 370,900 shares of company stock worth $5,905,400 in the last quarter. 5.94% of the stock is owned by insiders.
Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).
Receive News & Ratings for Teladoc Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc and related companies with MarketBeat.com's FREE daily email newsletter.